AIAI Holdings Corporation
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsAIAI Holdings Corp is a Delaware holding company that, after completing six acquisitions on May 6, 2026, operates a portfolio of construction, digital evidence, healthcare services, research, and document solutions businesses and listed its Class A common stock on Nasdaq.
What they do
AIAI was formed on July 19, 2024 for a direct listing and had no substantive operations before the May 6, 2026 closing. It now conducts substantially all operations through six wholly owned portfolio companies: CCCI (civil construction and project management in Central Texas), Constellation (digital evidence and blockchain-based data products for commercial and U.S. military uses), MediGuide (telehealth, medical second opinion, preventive health and medical treatment abroad), AIR (mathematical and scientific research for defense, national security and commercial AI), Vanguard (healthcare provider consulting, accident-victim case management and clinic advisory), and Bond Street (scanners, software, copiers, printers and subscription document services). The company licenses AI technology, including data sources, object code, APIs and template applications, from affiliate Messier 42, LLC under a perpetual-use AI License Agreement.
Revenue drivers
- Civil construction (CCCI) — Full-scope civil construction, project management and estimating for subdivisions, apartments, commercial sites, hospitals, industrial, educational and municipal projects in Central Texas; no separate segment revenue is disclosed in the excerpts.
- Digital evidence / blockchain (Constellation) — Hardware, software and enterprise divisions creating a trust-based exchange for a communications bridge, applied to U.S. military digital infrastructure; no separate segment revenue is disclosed.
- Healthcare services (MediGuide and Vanguard) — MediGuide sells telehealth, medical second opinion, preventive health and medical treatment abroad services; Vanguard provides physician and provider consulting, accident-victim case management and clinic advisory services; no separate segment revenue is disclosed.
- Document solutions (Bond Street) — Markets scanners, software, copiers, printers and subscription-based document solution services; no separate segment revenue is disclosed.
Recent performance
The company's reported revenue history reflects predecessor and successor periods around the May 6, 2026 closing: $65.2 million for the quarter ended June 30, 2025 and $78.1 million in a 2026 period, while the quarters ended March 31, 2025 and March 31, 2026 show $0.00. The 10-Q analyzes May 7, 2026 through June 30, 2026 as the Successor Period and April 1 through May 6, 2026 as the Current Predecessor Quarter, against prior predecessor periods. Annual net income for 2025 was -$3.9 million, with diluted EPS of -$4,664.21 and operating cash flow of -$2.5 million. At June 30, 2026, total assets were $1.31 billion, total liabilities $317.9 million and shareholder equity $996.0 million, with cash and equivalents of $11.2 million and long-term debt of $18.9 million.
Strategy
Management states the company's purpose is to create an AI-powered ecosystem by acquiring, integrating and scaling companies with high potential for improved operating results through the application of AI, and the six portfolio companies were acquired on May 6, 2026. It intends to implement AI-enabled solutions within the portfolio companies using licensed M42 AI Technology, for which it obtained a right of perpetual use under the AI License Agreement. The Class A common stock direct listing on the Nasdaq Global Market was completed on May 14, 2026, following the May 6, 2026 effectiveness of the Form S-1. No specific capital allocation, spend or integration targets beyond these steps are stated in the excerpts.
Risks
- Limited operating history as a combined company — AIAI had no substantive operations before the May 6, 2026 closing, so consolidated results exist only for the period after the acquisitions.
- Reliance on affiliated licensed technology — The AI-enabled solutions strategy depends on AI technology licensed from Messier 42, LLC, an entity under common control.
- Segment concentration in regulated and government-facing end markets — Constellation and AIR target U.S. military, defense and national security work, which carries government contracting and security-related exposure.
- Thin cash relative to balance sheet size — At June 30, 2026, cash and equivalents were $11.2 million against total assets of $1.31 billion and total liabilities of $317.9 million.
Outlook
The excerpts state that AIAI now conducts substantially all operations through the six portfolio companies acquired on May 6, 2026 and will implement AI-enabled solutions using the licensed M42 AI Technology. The 10-Q attributes forward-looking statements and additional risks to the Risk Factors section of the quarterly report. No revenue, earnings or liquidity guidance is provided in the supplied material.